Atlas Trials

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm

Clinical trial NCT00908869 · COMPLETED

Trial details

NCT number
NCT00908869
Sponsor
Institut Paoli-Calmettes
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Neoplasm
Start date
2006-05-01
Primary completion
2010-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.